An innovative case-study-based symposium focusing on multiple cardiovascular risk and management strategies was the theme of the Bayer HealthCare symposium at the ESC Congress 2005. More...
Adalat®’s impressive cardiovascular risk reductions in hypertensive patients were demonstrated with the release of the ACTION hypertension subanalysis results at the 15th ESH Congress. More...
One of the major cardiology meetings, Cardiology Update was the forum for the Bayer HealthCare symposium “Connecting prevention strategies for imptoving cardiovascular outcomes”. More...
